Hormone replacement and cardiotropic therapy in young men with hypertension, overweight, and androgen deficiency

DOI: https://doi.org/10.29296/25877305-2018-07-18
Download full text PDF
Issue: 
7
Year: 
2018

M. Khabibulina(1), Candidate of Medical Sciences, N. Fedorova(2) 1-Ural State Medical University, Yekaterinburg 2-Sverdlovsk Regional Clinical Hospital One, Yekaterinburg

Eighty-five men with hypertension, testosterone deficiency, and overweight were treated. The patients achieved a significantly effective result of 6-week treatment with minimal doses of a combined drug (10 mg lisinopril and 5 mg amlodipine) and minimal doses of hormone replacement therapy (transdermal gel 5 g and testosterone 50 mg daily). Early detection and timely treatment can prevent possible cardiovascular events. This therapy has a positive impact on blood pressure, vascular bed, erectile dysfunction, left cardiac remodeling, and psychological status.
Keywords: 
cardiology
endocrinology
hypertension
overweight
androgen deficiency
combined therapy

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Karpov Ju.A. Ingibitory APF: ot snizhenija AD do profilaktiki oslozhnenij i uluchshenija prognoza // Serdtse. – 2002; 4: 192–4.
  2. Postnikova S.L. IAPF v kardiologicheskoj praktike // Rus. med. zhurn. – 2004; 12 (7): 496–500.
  3. Habibulina M.M. Otsenka vlijanija dlitel'noj terapii ingibitorom angiotenzinprevraschajuschego fermenta lizinoprilom na morfofunktsional'nye pokazateli levogo zheludochka, disfunktsiju endotelija perifericheskih arterij, bezbolevuju ishemiju miokarda u zhenschin s gipertonicheskoj bolezn'ju v period premenopauzy // Kardiologija. – 2010; 1: 16–21.
  4. Habibulina M.M. Vlijanie iAPF lizinoprila na sostojanie sosudistogo rusla u zhenschin s AG v period premenopauzy // Kardiologija. – 2013; 2: 38–43.
  5. Djadyk A.I., Bagrij A.E., Jarovaja N.F. i dr. Vlijanie ingibitorov angiotenzinprevraschajuschego fermenta na gipertrofiju levogo zheludochka serdtsa u bol'nyh arterial'nymi gipertonijami // Ter. arh. – 1995; 8: 65–7.
  6. Orlova Ja.A., Mareev V.Ju., Sinitsin V.A. i dr. Vlijanie ingibitora angiotenzinprevraschajuschego fermenta enalaprila i serdechnogo glikozida digoksina na remodelirovanie levogo zheludochka // Kardiologija. – 1997; 2: 4–9.
  7. Veber V.R., Rubanova M.P. i dr. Effektivnost' nebivolola, amlodipina u bol'nyh AG zhenschin v postmenopauze s razlichnymi tipami remodelirovanija levogo zheludochka // Kardiovask. ter. i profilakt. – 2004; 3 (6, ch. 2): 15–9.
  8. Habibulina M.M. Kardiovaskuljarnyj risk pri estrogenodefitsite v doklimaktericheskih periodah / Ekaterinburg, 2014; 193 s.
  9. Rosmond R., Wallerius S., Wanger P. et al. A 5-year follow-up study of disease incidence in men with an abnormal hormone pattern // J. Intl. Med. – 2003; 254 (4): 386–90.
  10. Shores M., Matsumoto A., Sloan K. et al Low serum testosterone and mortality in male veterans // Arch. Intern. Med. – 2006; 166: 1660–5.
  11. Zigmond A., Snaith R. The hospital anxiety and depression scale // Acta Psychiatr. Scand. – 1983; 67: 361.
  12. Fedorova N.N., Habibulina M.M. Remodelirovanie levyh kamer serdtsa u muzhchin s AG pri normal'nom i izmenennom gormonal'nom fone // Vrach. – 2015; 12: 25–8.